Wednesday, October 16
3.0 CME CREDITS
As diagnosticians, pathologists must understand genomic testing. The cost of a whole exome sequence is approaching $1,000, and next-generation sequencing (NGS) has already led to personalized chemotherapy for cancer patients, which is being rapidly incorporated into patient care. Through lecture and interactive approaches, pathologists in academia and private practice will learn critical information regarding genomic medicine by attending this session. The presenters will provide key basics in molecular pathology followed by information on using microarray/NGS methodology, evaluating clinical utility of genomic tests in pathology, and communicating results to other clinicians. Members of a national genomics education committee who are experts in molecular pathology, medical education, and genetic counseling have developed the session.
You will learn to:
Richard L. Haspel, MD, PhD, FCAP
Debra G. Leonard, MD, PhD, FCAP
John D. Pfeifer, MD, PhD, FCAP